News | December 24, 2023
Bristol Myers Squibb to buy Karuna Therapeutics for US$ 14 billion
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Five batches across four programs of Biocon Academy participated in the graduation ceremony
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Subscribe To Our Newsletter & Stay Updated
